HPi2 monoclonal antibody supernatant from hybridoma HIC1-2B4 (endocrine cell marker)

Technology Overview

The monoclonal antibody HPi2 is derived from the hybridoma HIC1-2B4.  HPi2 selectively reacts with a cell surface module on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.
 
Antibody: HPi2 Supernatant
Hybridoma cell line: HIC1-2B4
Isotype: Mouse IgG1
Species reactivity: Human
Applications: Immunohistochemistry (acetone fixation recommended), Flow cytometry
Availability:  1mL supernatant aliquot.
 
 
 
Patent Information:
Direct Link:
https://canberra-ip.technologypublisher.com/tech/HPi2_monoclonal_antibody_sup ernatant_from_hybridoma_HIC1-2B4_(endocrine_cell_marker)
Keywords:
Bookmark this page
For Information, Contact:
Cadence True
Technology Collaboration Manager
Oregon Health & Science University
trueca@ohsu.edu